Free Trial

Oncology Institute (TOI) Competitors

Oncology Institute logo
$2.99 +0.32 (+11.99%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$3.12 +0.13 (+4.18%)
As of 07:51 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TOI vs. FLGT, FTRE, EHAB, TALK, AUNA, INNV, CSTL, PSNL, CELC, and LFMD

Should you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include Fulgent Genetics (FLGT), Fortrea (FTRE), Enhabit (EHAB), Talkspace (TALK), Auna (AUNA), InnovAge (INNV), Castle Biosciences (CSTL), Personalis (PSNL), Celcuity (CELC), and LifeMD (LFMD). These companies are all part of the "healthcare" industry.

Oncology Institute vs.

Fulgent Genetics (NASDAQ:FLGT) and Oncology Institute (NASDAQ:TOI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation, community ranking and institutional ownership.

48.1% of Fulgent Genetics shares are owned by institutional investors. Comparatively, 36.9% of Oncology Institute shares are owned by institutional investors. 31.8% of Fulgent Genetics shares are owned by company insiders. Comparatively, 8.5% of Oncology Institute shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Fulgent Genetics received 240 more outperform votes than Oncology Institute when rated by MarketBeat users. However, 71.43% of users gave Oncology Institute an outperform vote while only 59.76% of users gave Fulgent Genetics an outperform vote.

CompanyUnderperformOutperform
Fulgent GeneticsOutperform Votes
245
59.76%
Underperform Votes
165
40.24%
Oncology InstituteOutperform Votes
5
71.43%
Underperform Votes
2
28.57%

In the previous week, Fulgent Genetics had 4 more articles in the media than Oncology Institute. MarketBeat recorded 8 mentions for Fulgent Genetics and 4 mentions for Oncology Institute. Fulgent Genetics' average media sentiment score of 0.97 beat Oncology Institute's score of 0.13 indicating that Fulgent Genetics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fulgent Genetics
3 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Oncology Institute
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Fulgent Genetics currently has a consensus price target of $24.00, indicating a potential upside of 16.96%. Oncology Institute has a consensus price target of $7.00, indicating a potential upside of 134.11%. Given Oncology Institute's stronger consensus rating and higher possible upside, analysts clearly believe Oncology Institute is more favorable than Fulgent Genetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fulgent Genetics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Oncology Institute
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Oncology Institute has higher revenue and earnings than Fulgent Genetics. Fulgent Genetics is trading at a lower price-to-earnings ratio than Oncology Institute, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fulgent Genetics$292.45M2.14-$167.82M-$1.33-15.43
Oncology Institute$403.15M0.56-$83.07M-$0.70-4.27

Oncology Institute has a net margin of -17.63% compared to Fulgent Genetics' net margin of -59.39%. Fulgent Genetics' return on equity of -1.81% beat Oncology Institute's return on equity.

Company Net Margins Return on Equity Return on Assets
Fulgent Genetics-59.39% -1.81% -1.66%
Oncology Institute -17.63%-186.83%-34.58%

Fulgent Genetics has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.Comparatively, Oncology Institute has a beta of 0.04, meaning that its share price is 96% less volatile than the S&P 500.

Summary

Fulgent Genetics beats Oncology Institute on 10 of the 17 factors compared between the two stocks.

Get Oncology Institute News Delivered to You Automatically

Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TOI vs. The Competition

MetricOncology InstituteOffices & clinics of medical doctors IndustryMedical SectorNASDAQ Exchange
Market Cap$225.92M$1.69B$5.33B$8.39B
Dividend YieldN/AN/A5.21%4.11%
P/E Ratio-3.8327.9326.7119.71
Price / Sales0.561.57386.08120.53
Price / CashN/A36.0138.2534.62
Price / Book3.8816.816.774.50
Net Income-$83.07M-$52.07M$3.23B$248.22M
7 Day Performance-1.64%3.46%1.80%0.56%
1 Month Performance10.33%48.95%11.10%13.17%
1 Year Performance424.47%81.92%17.11%7.30%

Oncology Institute Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TOI
Oncology Institute
2.2358 of 5 stars
$2.99
+12.0%
$7.00
+134.1%
+424.5%$225.92M$403.15M-3.83660Insider Trade
FLGT
Fulgent Genetics
3.964 of 5 stars
$20.12
+2.1%
$24.00
+19.3%
-3.9%$612.53M$292.45M-3.641,010News Coverage
FTRE
Fortrea
3.4151 of 5 stars
$5.19
-15.6%
$15.82
+204.8%
-83.9%$556.82M$2.70B-1.5218,000Positive News
Analyst Forecast
High Trading Volume
EHAB
Enhabit
2.0674 of 5 stars
$10.44
+1.5%
$8.50
-18.5%
+9.0%$528.40M$1.03B-4.5010,900Positive News
TALK
Talkspace
3.7243 of 5 stars
$3.08
+2.0%
$4.50
+46.1%
+0.0%$518.79M$194.36M308.31500Positive News
AUNA
Auna
3.4532 of 5 stars
$6.96
+1.4%
$13.50
+94.1%
-23.1%$514.46M$4.39B18.3014,958News Coverage
Earnings Report
Analyst Forecast
INNV
InnovAge
0.9185 of 5 stars
$3.80
+4.4%
$5.00
+31.6%
-11.6%$513.93M$806.61M-20.002,000
CSTL
Castle Biosciences
3.0152 of 5 stars
$17.04
+1.5%
$37.50
+120.1%
-35.1%$491.98M$347.08M85.20540Positive News
Analyst Forecast
PSNL
Personalis
4.3381 of 5 stars
$5.10
+1.2%
$8.00
+56.9%
+197.1%$450.37M$84.61M-3.04400
CELC
Celcuity
1.9153 of 5 stars
$10.68
+5.2%
$30.17
+182.5%
-32.8%$404.12MN/A-4.0940Trending News
Analyst Revision
LFMD
LifeMD
1.4156 of 5 stars
$8.55
+3.5%
$11.00
+28.7%
+47.6%$388.58M$234.01M-13.36230News Coverage
Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:TOI) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners